The Future of Mental Healthcare Summit is the dedicated meeting point for leaders from across healthcare to come together and reimagine the next generation of behavioral health. As an industry,...
This two-day event provides updates on global and domestic regulatory updates, policy issues and discusses various payment models and payment pathways for medical devices, diagnostics, drug delivery, and digital health...
Join Mansfield Bio-Incubator for the $80K Pitch Competition, an exciting day of life science innovation, networking and opportunity. This event will feature start-ups in biotech, pharma, medtech, life sciences, and...
The MLSC is partnering with MassBio and industry leaders in the Commonwealth at this year's BIO International Convention, held in Boston, MA. Visit booth #435 to learn more about why...
MassBio is celebrating 40 years of innovation and community at a special evening event during the BIO International Convention. On Tuesday, June 17, our partners at MassBio invite you to join us...
In its 23rd year, Discovery on Target is the premier event highlighting “hot” drug targets and emerging modalities, technologies, and strategies for pursuing those targets. The numerous conferences, symposia, courses,...
Unless otherwise specifically stated in relation to each and any of the events listed on this page, the MLSC does not host or sponsor these events. The MLSC has no oversight or responsibility for the venue, content or host-organization related to these events. The MLSC has no affiliation with the organizations listing events or with the events and provides this content and information as a convenience to visitors to the MLSC website.
Olaris is a precision diagnostics company that is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging their CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes), which combines metabolomics and machine learning, they are able to harness the power of the body’s own communication system to discover and develop their pipeline of myOLARIS precision diagnostics.
Notifications
